Associate Professor | Johns Hopkins Bloomberg School of Public Health
Professor Socal’s research focuses on improving pharmaceutical access and affordability. Specific topics include the global pharmaceutical supply chain, gene therapies, generics and biosimilar markets, and ways to control spending without restricting access to prescription drugs. Prof. Socal has testified before the U.S. Congress on the drug pricing provisions established in the Inflation Reduction Act. Prof. Socal also testified at the Food and Drug Administration on biopharmaceutical regulation, including insulins. Prof. Socal collaborates with state-level initiatives to increase access to prescription drugs, including the California Generic Drugs Initiative (CalRx). Prof. Socal is a physician trained in adult Neurology. She holds a Master’s in Public Policy from Princeton University and a PhD in Public Health/Health Systems from Johns Hopkins University. Prof. Socal teaches courses on U.S. Pharmaceutical Policy and the U.S. Health Care System.
